Manufacturing roundup: Mustang Bio closes sale with uBriGene; Indian syrup manufacturer halts production after government order

Mus­tang Bio has both amend­ed and closed the agree­ment with CD­MO uBri­Gene, to sell Mus­tang’s man­u­fac­tur­ing fa­cil­i­ty.

The new agree­ment will see uBri­Gene ac­quir­ing all of Mus­tang’s as­sets re­lat­ed to man­u­fac­tur­ing cell and gene ther­a­pies for $6 mil­lion up­front in cash. Ac­cord­ing to a re­lease, the lease to Mus­tang’s 27,000-square-foot fa­cil­i­ty in Worces­ter, MA, is not yet a part of the deal be­cause the land­lord is tak­ing more time to con­sid­er the trans­fer. 

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters